Skip to content

MEDI SEM: what changed

BE 0442.879.036NACE 86.210, General medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€63,474
2024 · €57,191+€6,283
Equity
€830,562
2024 · €767,088+€63,474
Cash
€811,448
2024 · €748,232+€63,217
Balance sheet total
€831,371
2024 · €767,250+€64,121

Largest movements

2024 to 2025
Assets
  • Cash +€63,217

    up €63,217 (+8.4%), from €748,232 to €811,448

    mainly Net result for the year (+€63,474) and Trade debts (+€647)

Equity and liabilities
  • Reserves +€63,474

    up €63,474 (+8.4%), from €754,696 to €818,170

Income statement
  • Gross operating margin +€4,316

    up €4,316 (+5.3%), from €80,690 to €85,006

  • Financial income +€2,496

    up €2,496 (+46.2%), from €5,407 to €7,902

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €57,191
Gross operating margin +€4,316
Depreciation +€45
Other operating charges -€12
Financial income +€2,496
Financial charges -€101
Taxes -€461
Result 2025 €63,474
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€63,217
Investment €0
Financing €0
Cash 2024 €748,232
Net result for the year +€63,474
Depreciation +€344
Receivables within one year -€1,195
Deferred charges and accrued income -€54
Trade debts +€647
Cash 2025 €811,448
brings cash intakes cash out
Every line side by side 31 lines
Line Code 2024 2025 Change %
Total assets 20/58 €767,250 €831,371 +€64,121 +8.4%
Fixed assets 21/28 €642 €298 -€344 -53.6%
Tangible fixed assets 22/27 €642 €298 -€344 -53.6%
Furniture and vehicles 24 €642 €298 -€344 -53.6%
Current assets 29/58 €766,608 €831,073 +€64,465 +8.4%
Amounts receivable within one year 40/41 €15,850 €17,045 +€1,195 +7.5%
Trade receivables 40 - €1,248 +€1,248
Other amounts receivable 41 €15,850 €15,796 -€54 -0.3%
Cash at bank and in hand 54/58 €748,232 €811,448 +€63,217 +8.4%
Deferred charges and accrued income 490/1 €2,526 €2,580 +€54 +2.1%
Total equity and liabilities 10/49 €767,250 €831,371 +€64,121 +8.4%
Equity 10/15 €767,088 €830,562 +€63,474 +8.3%
Contributions 10/11 €12,392 €12,392 = 0.0%
Reserves 13 €754,696 €818,170 +€63,474 +8.4%
Distributable reserves 133 €754,696 €818,170 +€63,474 +8.4%
Amounts payable 17/49 €162 €809 +€647 +399%
Amounts payable within one year 42/48 €162 €809 +€647 +399%
Trade debts 44 €162 €809 +€647 +399%
Suppliers 440/4 €162 €809 +€647 +399%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €389 €344 -€45 -11.6%
Other operating charges 640/8 €437 €450 +€12 +2.8%
Gross operating margin 9900 €80,690 €85,006 +€4,316 +5.3%
Operating profit (loss) 9901 €79,863 €84,212 +€4,349 +5.4%
Financial income 75/76B €5,407 €7,902 +€2,496 +46.2%
Recurring financial income 75 €5,407 €7,902 +€2,496 +46.2%
Financial charges 65/66B €841 €941 +€101 +12.0%
Recurring financial charges 65 €841 €941 +€101 +12.0%
Profit (loss) for the period before taxes 9903 €84,429 €91,173 +€6,744 +8.0%
Income taxes 67/77 €27,238 €27,698 +€461 +1.7%
Profit (loss) for the period 9904 €57,191 €63,474 +€6,283 +11.0%
Profit (loss) for the period to be appropriated 9905 €57,191 €63,474 +€6,283 +11.0%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€621,524 to €704,021

Midpoint €655,898 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €830,562
Capitalised earnings €412,486 to €577,480
Indication €621,524 to €704,021

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€830,562
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€830,562

Capitalised earnings

net result for the year (9904)
2025
€63,474
2024
€57,191
2023
€52,487
excluding non-recurring income and charges
€52,577
2022
€53,789
2021
€58,360
Average result, excluding non-recurring income and charges
€57,748
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€412,486 / €481,233 / €577,480

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 13 November 2026 via checked.be.